RWE ALGORITHMS - THE BUILDING BLOCKS OF RWE QUALITY
Author(s)
Murray J1, Beyrer J2, Abedtash H1, Hornbuckle K1
1Eli Lilly and Company, Indianapolis, IN, USA, 2Eli Lilly and Company, Okeana, OH, USA
Presentation Documents
OBJECTIVES RWE studies addressing the same research question using the same data and analysis methods may arrive at different results and conclusions. This variability in practice suggests bias, unmeasured confounders, and undesirable heterogeneity that may cause an inability to validate and replicate results. There is a growing body of work about the need for the quality and relevance of real world data as well as the transparency and replicability of RWE. We explore why variability may occur in a fundamental building block of RWE, the “algorithm.” An algorithm is a set of rules to be followed in calculations or problem-solving operations. RWE algorithms are comprised of real-world data, coding schemes, metadata, and logic. We address four types of algorithms: cohort and subgroup identification, exposures, other covariates, and outcomes measures. While algorithms may be transparent, the criteria used to evaluate whether they are “fit-for-purpose,” including their “operating characteristics,” are often not. METHODS We looked for standards and recommendations from regulatory bodies (i.e., FDA, EMA, ICH), other governmental agencies (i.e., AHRQ, PCORI), external agencies (i.e., Duke Margolis), payer organizations (i.e., NCQA, NQF), and professional societies (i.e., ISPOR, ISPE). We abstracted the criteria proposed by which algorithms should be evaluated as well as statistics and operating characteristics to be reported. RESULTS Our research yielded the following recommended criteria: Clinical importance, Data Quality, Feasibility, Interpretation of scores (Outcomes), Relevance, Reliability or reproducibility, Responsiveness, Safety (i.e., no harm to subjects), Transparency & Replicability, and Validity. Specific statistic recommendations are: Sensitivity, Specificity and Positive & Negative Value, Sample size available as well as other appropriate measures of and validity and reliability. The presentation will define and map these criteria to their source with the evaluation metrics. CONCLUSIONS Applying these criteria for algorithms allow RWE to be judged both on its transparency and quality.
Conference/Value in Health Info
2020-05, ISPOR 2020, Orlando, FL, USA
Value in Health, Volume 23, Issue 5, S1 (May 2020)
Code
PNS219
Topic
Epidemiology & Public Health, Organizational Practices, Real World Data & Information Systems
Topic Subcategory
Best Research Practices, Disease Classification & Coding, Industry, Reproducibility & Replicability
Disease
No Specific Disease